Dr. Marty Tenenbaum, Chairman and co-Founder of CollabRx recently spoke at the Open Science Summit 2011 about Open Medicine and Clinical Trials 2.0. Dr. Tenenbaum described the concept of an open community that compiles and continually refines information about cancer subtypes and treatments based on actual patient outcomes.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply